68640 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Eunice Kennedy 

Shriver National Institute of Child 

Health and Human Development 

Special Emphasis Panel Specialized 

Centers for Research on Health 

Disparities in Uterine Leiomyoma 

(SCHDUL) (Clinical Trial Not Allowed). 

Date: November 29–30, 2023. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, 6710B Rockledge Drive, 

Room 2125C, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Magnus A. Azuine, 

Ph.D., Scientific Review Officer, 

Scientific Review Branch, Eunice 

Kennedy Shriver National Institute of 

Child Health and Human Development, 

National Institutes of Health, 6710B 

Rockledge Drive, Room 2125C, 

Bethesda, MD 20817, (301) 480–4645, 

magnus.azuine@nih.gov. 

Name of Committee: Eunice Kennedy 

Shriver National Institute of Child 

Health and Human Development 

Special Emphasis Panel Function, 

Integration, and Rehabilitation/Member 

Conflict. 

Date: December 4, 2023. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, 6710B Rockledge Drive, 

Room 2125D, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Moushumi Paul, 

Ph.D., Scientific Review Officer, 

Scientific Review Branch, Eunice 

Kennedy Shriver National Institute of 

Child Health and Human Development, 

National Institutes of Health, 6710B 

Rockledge Drive, Room 2125D, 

Bethesda, MD 20892, (301) 496–3596, 

moushumi.paul@nih.gov 

(Catalogue of Federal Domestic 

Assistance Program Nos. 93.864, 

Population Research; 93.865, Research 

for Mothers and Children, National 

Institutes of Health, HHS) 

Dated: September 29, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst,Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–22030 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

BRAIN Initiative: Data Integration and 

Analysis, Experimental Standards, and 

Archives. 

Date: November 20, 2023. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Nicholas Gaiano, Ph.D., 

Review Branch Chief, Division of Extramural 

Activities, National Institute of Mental 

Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Bethesda, MD 20892–9606, 301– 

443–2742, nick.gaiano@nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Early 

Phase Clinical Trials: Pharma/Device and K 

Awards. 

Date: November 28, 2023. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Regina Dolan-Sewell, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Bethesda, MD 20852, (240) 796–6785, 

regina.dolan-sewell@nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Jointly Sponsored Institutional Predoctoral 

Training Programs in the Neurosciences 

(T32). 

Date: November 29, 2023. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Jasenka Borzan, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Neuroscience Center, 

Bethesda, MD 20892, 301–435–1260, 

jasenka.borzan@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: September 28, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21891 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel RFA Panel: 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68641 

Understanding Neurological Effects of 

COVID–19 and PASC. 

Date: November 2–3, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Todd Everett White, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–3962, todd.white@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowships: 

Neurodevelopment, Oxidative Stress, and 

Synaptic Plasticity Fellowship Study 

Section. 

Date: November 7–8, 2023. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Robert C. Elliott, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5190, 

MSC 7846, Bethesda, MD 20892, 301–435– 

3009, elliotro@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Health Services and Systems. 

Date: November 13, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Debasmita Patra, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1006E, 

Bethesda, MD 20892, (301) 827–5187, 

debasmita.patra@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Small 

Business: The Cardiovascular and 

Hematological Sciences. 

Date: November 14–15, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The William F. Bolger Center, 9600 

Newbridge Drive, Potomac, MD 20854. 

Contact Person: Dmitri V. Gnatenko, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 867–5309, gnatenkod2@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel RFA Panel: 

Small Research grants for Data Analysis, 

Exploratory/Developmental Research, 

Clinical Trials Readiness, Phased Innovation, 

and Clinical Research Course Development 

in Down Syndrome for the INCLUDE Project. 

Date: November 15, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Courtney Elaine Watkins, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 496–3093, courtney.watkins2@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowships: 

Infectious Diseases and Immunology B. 

Date: November 15–16, 2023. 

Time: 10:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Diana Maria Ortiz-Garcia, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–5614, diana.ortiz-garcia@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Cancer Biology. 

Date: November 15, 2023. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Manzoor A. Zarger, Ph.D., 

MS, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6208, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

2477, zargerma@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Small 

Business: Health Services and Systems. 

Date: November 16–17, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Michael J. McQuestion, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

Bethesda, MD 20892, 301–480–1276, 

mike.mcquestion@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel RFA Panel: 

Transformative Research and Fellowships in 

Down Syndrome for the INCLUDE Project. 

Date: November 16, 2023. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Courtney Elaine Watkins, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 496–3093, courtney.watkins2@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Mechanisms of Neurodegeneration. 

Date: November 16, 2023. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Roger Alan Bannister, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1010–D, 

Bethesda, MD 20892, (301) 435–1042, 

bannisterra@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Topics in Immunology and 

Infectious Diseases. 

Date: November 17, 2023. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kenneth M. Izumi, Ph.D., 

Scientific Review Officer, NIH, Center for 

Scientific Review, 6701 Rockledge Drive, 

MSC 7808, Bethesda, MD 20892, 301–496– 

6980, izumikm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Topics in Pathogenic Eukaryotes. 

Date: November 20, 2023. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Neerja Kaushik-Basu, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

1742, kaushikbasun@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowships: 

Vascular and Hematological Systems, 

Surgical Sciences, Biomedical Imaging, and 

Bioengineering. 

Date: November 20, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ai-Ping Zou, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–408– 

9497, zouai@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel PAR23–156: 

Lasker Clinical Research Scholars Program. 

Date: November 21, 2023. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 


lotter on DSK11XQN23PROD with NOTICES1
68642 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

Contact Person: Lawrence Ka-Yun Ng, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1719, ngkl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Vascular Biology and Hematology. 

Date: November 29, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Courtney Elaine Watkins, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 496–3093, courtney.watkins2@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Hematology and Vascular 

Pathophysiology. 

Date: November 29, 2023. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ai-Ping Zou, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

Bethesda, MD 20892, (301) 408–9497, zouai@

csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowships: 

Physiology and Pathobiology of 

Cardiovascular and Respiratory Systems. 

Date: November 30–December 1, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kimm Hamann, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118A, 

MSC 7814, Bethesda, MD 20892, 301–435– 

5575, hamannkj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Topics in Bacterial Virulence and 

Bacterial-Host Interactions. 

Date: November 30, 2023. 

Time: 1:30 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Liying Guo, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4198, 

MSC 7812, Bethesda, MD 20892, (301) 827– 

7728, lguo@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 28, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21888 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Tribal Opioid Response (TOR) 

Consultation 

AGENCY: Substance Abuse and Mental 

Health Services Administration 

(SAMHSA), HHS. 

ACTION: Notice of meeting and request 

for testimony. 

SUMMARY: SAMHSA announces a Tribal 

Consultation Session on the Tribal 

Opioid Response (TOR) grant funding 

methodology. SAMHSA will host 

American Indian and Alaska Native 

(AI/AN) Federally Recognized Tribes for 

a virtual Tribal consultation session. 

DATES: The Tribal consultation will be 

held on November 9th, at 2 p.m. ET. 

SAMHSA will accept written Tribal 

testimony until 5 p.m., November 23rd, 

2023. 

ADDRESSES: Written tribal testimony 

should be submitted by email to otap@

samhsa.hhs.gov. All submissions must 

include Tribal affiliation. All relevant 

comments, including any personal 

information provided, will be posted 

without change. 

FOR FURTHER INFORMATION CONTACT: 

Karen Hearod, MSW, LCSW, Director, 

Office of Tribal Affairs and Policy, 

Substance Abuse and Mental Health 

Services Administration, Telephone: 

202–868–9931, Email: otap@

samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: Federally 

Recognized Indian Tribes represented 

by the Tribal President, Tribal Chair, or 

Tribal Governor, or an elected or 

appointed Tribal Leader, or their 

authorized representative(s) may 

participate in this consultation by 

submitting written views, opinions, 

recommendations, and data. Testimony 

received, including attachments and 

other supporting materials, are part of 

the public record and subject to public 

disclosure. Do not include any 

information in your testimony or 

supporting materials considered 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other personal 

identifiers in the body of your 

testimony, that information will be on 

public display. SAMHSA will review all 

submissions and may choose to redact, 

or withhold, submissions containing 

private or proprietary information such 

as Social Security numbers, medical 

information, inappropriate language, or 

duplicate/near duplicate examples of a 

mass-mail campaign. SAMHSA will 

carefully consider all testimony 

submitted into the docket. 

Oral Tribal Testimony: Based on the 

number of participants giving testimony 

and the time available, it may be 

necessary to limit speaking times for 

each presenter. We will adjourn the 

Tribal consultation meeting early if all 

attendees who requested to provide oral 

testimony in advance of and during the 

consultation have delivered their 

testimony. 

Written Tribal Testimony: Written 

testimony will be accepted per the 

instructions provided in the ADDRESSES

section above. Written testimony 

received in advance of the meeting will 

be included in the official record of the 

meeting. The consultation meeting will 

be recorded, transcribed, and posted 

without change to https://

www.samhsa.gov/tribal-affairs/newsevents, including any personal 

information provided. 

This meeting is being held in 

accordance with Presidential Executive 

Order No. 13175, November 6, 2000, 

and Presidential Memorandums of 

November 5, 2009, and September 23, 

2004, and January 26, 2021 on 

Consultation and Coordination with 

Indian Tribal Government and 

SAMHSA’s Tribal Consultation Policy, 

which can be found at: https://

www.samhsa.gov/sites/default/files/ 

topics/tribal_affairs/tribal-consultationpolicy-2017.pdf. 

Purpose: The purpose of this 

Consultation meeting is to advance 

SAMHSA support for, and collaboration 

with, federally recognized American 

Indian and Alaska Native (AI/AN) 

Tribes. To advance these goals, 

SAMHSA conducts government-togovernment consultations with Indian 

Tribes represented by the Tribal 

President, Tribal Chair, or Tribal 

Governor, or an elected or appointed 

Tribal Leader, or their authorized 

representative(s) to the extent 

practicable and permitted by law before 

SAMHSA takes any action that will 

significantly affect Indian Tribes. 

Consultation is an enhanced form of 

communication that emphasizes trust, 

respect, and shared responsibility. It is 

an open and free exchange of 


lotter on DSK11XQN23PROD with NOTICES1